(VIANEWS) – Casella Waste Systems (CWST), Zynex (ZYXI), The Descartes Systems Group (DSGX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Casella Waste Systems (CWST)
26.4% sales growth and 5.47% return on equity
Casella Waste Systems, Inc., together with its subsidiaries, operates as a vertically integrated solid waste services company in the northeastern United States. It offers resource management services primarily in the areas of solid waste collection and disposal, transfer, recycling, and organics services to residential, commercial, municipal, and industrial customers. The company provides a range of non-hazardous solid waste services, including collections, transfer stations, and disposal facilities. It also markets recyclable metals, aluminum, plastics, and paper and corrugated cardboard that are processed at its facilities, as well as recyclables purchased from third parties. In addition, the company is involved in commodity brokerage operations. As of April 15, 2021, it owned and/or operated 46 solid waste collection operations, 58 transfer stations, 20 recycling facilities, 8 Subtitle D landfills, 4 landfill gas-to-energy facilities, and 1 landfill permitted to accept construction and demolition materials. The company was founded in 1975 and is headquartered in Rutland, Vermont.
Earnings Per Share
As for profitability, Casella Waste Systems has a trailing twelve months EPS of $0.78.
PE Ratio
Casella Waste Systems has a trailing twelve months price to earnings ratio of 99.99. Meaning, the purchaser of the share is investing $99.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.47%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Casella Waste Systems’s EBITDA is 4.54.
2. Zynex (ZYXI)
17.2% sales growth and 26.28% return on equity
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Earnings Per Share
As for profitability, Zynex has a trailing twelve months EPS of $0.46.
PE Ratio
Zynex has a trailing twelve months price to earnings ratio of 17.65. Meaning, the purchaser of the share is investing $17.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.28%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.3%, now sitting on 177.45M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Zynex’s EBITDA is 64.85.
3. The Descartes Systems Group (DSGX)
16.9% sales growth and 10.28% return on equity
The Descartes Systems Group Inc. provides cloud-based logistics and supply chain management business process solutions that focuses on enhancing the productivity, performance, and security of logistics-intensive businesses worldwide. Its Logistics Technology platform offers a range of modular, cloud-based, and interoperable web and wireless logistics management applications, which unites a community of logistics-focused parties, allowing them to transact business. The company provides a suite of solutions that include routing, mobile and telematics; transportation management and e-commerce enablement; customs and regulatory compliance; trade data; global logistics network services; and broker and forwarder enterprise systems. It offers its customers to use its modular, software-as-a-service, and data solutions to route, schedule, track, and measure delivery resources; plan, allocate, and execute shipments; rate, audit, and pay transportation invoices; access and analyze global trade data; research and perform trade tariff and duty calculations; file customs and security documents for imports and exports; and various other logistics processes. The company also provides cloud-based ecommerce warehouse management solutions; consulting, implementation, and training services; and maintenance and support services. It primarily focuses on serving transportation providers, logistics service providers, and distribution-intensive companies, as well as manufacturers, retailers, distributors, and mobile business service providers. The company was incorporated in 1981 and is headquartered in Waterloo, Canada.
Earnings Per Share
As for profitability, The Descartes Systems Group has a trailing twelve months EPS of $1.31.
PE Ratio
The Descartes Systems Group has a trailing twelve months price to earnings ratio of 55.01. Meaning, the purchaser of the share is investing $55.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.28%.
4. Intuitive Surgical (ISRG)
15.7% sales growth and 12.05% return on equity
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Earnings Per Share
As for profitability, Intuitive Surgical has a trailing twelve months EPS of $3.97.
PE Ratio
Intuitive Surgical has a trailing twelve months price to earnings ratio of 75.27. Meaning, the purchaser of the share is investing $75.27 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.05%.
Yearly Top and Bottom Value
Intuitive Surgical’s stock is valued at $298.83 at 06:22 EST, way below its 52-week high of $358.07 and way above its 52-week low of $180.07.
Sales Growth
Intuitive Surgical’s sales growth is 16.7% for the current quarter and 15.7% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Intuitive Surgical’s EBITDA is 250.39.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.4%, now sitting on 6.66B for the twelve trailing months.
5. HireQuest (HQI)
7.7% sales growth and 19.41% return on equity
HireQuest, Inc. provides on-demand and temporary staffing solutions in the United States. The company provides temporary staffing services, including skilled and semi-skilled labor and industrial personnel, clerical and administrative personnel, and construction personnel. As of March 25, 2021, the company had a network of approximately 139 franchisee-owned offices in 35 states and the District of Columbia. It serves customers primarily in the construction, industrial/manufacturing, warehousing, hospitality, recycling/waste management, disaster recovery, logistics, auctioneering, landscaping, and retail industries. The company was formerly known as Command Center, Inc. and changed its name to HireQuest, Inc. in September 2019. HireQuest, Inc. was founded in 2002 and is headquartered in Goose Creek, South Carolina.
Earnings Per Share
As for profitability, HireQuest has a trailing twelve months EPS of $0.8.
PE Ratio
HireQuest has a trailing twelve months price to earnings ratio of 18.91. Meaning, the purchaser of the share is investing $18.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.41%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
HireQuest’s EBITDA is 106.41.
Volume
Today’s last reported volume for HireQuest is 23196 which is 7.05% below its average volume of 24957.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.4%, now sitting on 34.76M for the twelve trailing months.
